Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 9/20 | 0.59 |
| ▸ | CCNB1 | P14635 | 6/20 | 0.59 |
| ▸ | CCNE1 | P24864 | 6/20 | 0.59 |
| ▸ | CDK2 | P24941 | 6/20 | 0.59 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.46 |
| ▸ | YTHDC1 | Q96MU7 | 1/20 | 0.40 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.38 |
| ▸ | PDE4A | P27815 | 1/20 | 0.37 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.37 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.37 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.37 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.36 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6368852 | 0.81 | CDK1 (0.44) | CDK1CCNB1CCNE1CDK2ADORA2A | |
| SCHEMBL129642 | 0.81 | CDK1 (0.68) | CDK1CCNB1CCNE1CDK2ADORA2A | |
| SCHEMBL27392700 | 0.79 | CDK1 (0.43) | CDK1CCNB1CCNE1CDK2ADORA2A | |
| SCHEMBL10148680 | 0.79 | CDK1 (0.57) | CDK1CCNB1CCNE1CDK2ADORA2A | |
| SCHEMBL27531530 | 0.79 | CDK2 (0.39) | CDK1CCNB1CCNE1CDK2ADORA2A | |
| SCHEMBL23027205 | 0.78 | CDK1 (0.42) | CDK1CCNB1CCNE1CDK2ADORA2A | |
| SCHEMBL7625861 | 0.78 | CDK2 (0.38) | CDK1CCNB1CCNE1CDK2CYP2C19 | |
| SCHEMBL17226007 | 0.78 | CDK1 (0.55) | CDK1CCNB1CCNE1CDK2ADORA2A | |
| SCHEMBL764036 | 0.78 | CDK1 (0.59) | CDK1CCNB1CCNE1CDK2ADORA2A | |
| SCHEMBL17860490 | 0.77 | CCNE1 (0.71) | CDK1CCNB1CCNE1CDK2ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117821287-A | Strain for specifically degrading 9-methylguanine and screening method thereof | 安徽大学 | 2024-04-05 | — | — | CN | claimed |
| EP-4689108-A1 | SMAD7 INHIBITORY ANTISENSE OLIGONUCLEOTIDES (ASO) FOR TREATING POUCHITIS AND METHODS OF USING THE SAME | Nogra Pharma Limited (IE) | 2026-02-11 | — | — | EP | disclosed |
| CN-117821287-B | Strain for specifically degrading 9-methylguanine and screening method thereof | 安徽大学 | 2026-02-03 | — | — | CN | disclosed |
| CN-117821287-B | Strain for specifically degrading 9-methylguanine and screening method thereof | 安徽大学 | 2026-02-03 | — | — | CN | disclosed |
| EP-4479034-A1 | CAPSAICIN DERIVATIVES AS BIOENHANCERS ON ACTIVE SUBSTANCES METABOLIZED BY CYP1A2 AND CYP2D6 | aXichem AB (SE) | 2024-12-25 | — | — | EP | disclosed |
| CN-119053326-A | Capsaicin derivatives as bioenhancers of active substances metabolized by CYP1A2 and CYP2D6 | 艾克西化学公司 | 2024-11-29 | — | — | CN | disclosed |
| WO-2024200594-A1 | SMAD7 INHIBITORY ANTISENSE OLIGONUCLEOTIDES (ASO) FOR TREATING POUCHITIS AND METHODS OF USING THE SAME | NOGRA PHARMA LIMITED (IE) | 2024-10-03 | — | — | WO | disclosed |
| CN-117821287-A | Strain for specifically degrading 9-methylguanine and screening method thereof | 安徽大学 | 2024-04-05 | — | — | CN | disclosed |
| CN-117821287-A | Strain for specifically degrading 9-methylguanine and screening method thereof | 安徽大学 | 2024-04-05 | — | — | CN | disclosed |
| CN-117821287-A | Strain for specifically degrading 9-methylguanine and screening method thereof | 安徽大学 | 2024-04-05 | — | — | CN | disclosed |
| WO-2005039648-A2 | USE OF METAL TRICARBONYL COMPLEXES AS RADIOTHERAPEUTIC CHEMOTOXIC AGENTS | Universität Zürich (CH) | 2005-05-06 | — | — | WO | disclosed |
| EP-0755255-A4 | TREATMENT OF TOXOPLASMOSIS | RES CORP TECHNOLOGIES INC (US) | 2002-07-24 | — | — | EP | disclosed |
| US-5773424-A | PARASITICIDE | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1998-06-30 | — | — | US | disclosed |
| EP-0755255-A1 | TREATMENT OF TOXOPLASMOSIS | UNIVERSITY OF ALABAMA, BIRMINGHAM RESEARCH FOUNDATION (US) | 1997-01-29 | — | — | EP | disclosed |
| WO-1996018398-A1 | TREATMENT OF TOXOPLASMOSIS | THE UNIVERSITY OF ALABAMA AT BIRMINGHAM RESEARCH FOUNDATION (US) | 1996-06-20 | — | — | WO | disclosed |
| EP-0464112-B1 | A PROCESS FOR THE PREPARATION OF 9-SUBSTITUTED GUANINE DERIVATIVES AND INTERMEDIATES FOR USE IN THE PROCESS | GEA FARMACEUTISK FABRIK AS (DK) | 1994-10-05 | — | — | EP | disclosed |
| US-5223619-A | Catalytic cyclization | A/S GEA FARMACEUTISK FABRIK (DK) | 1993-06-29 | — | — | US | disclosed |
| EP-0464112-A1 | A PROCESS FOR THE PREPARATION OF 9-SUBSTITUTED GUANINE DERIVATIVES AND INTERMEDIATES FOR USE IN THE PROCESS. | GEA FARMACEUTISK FABRIK AS (DK) | 1992-01-08 | — | — | EP | disclosed |
| WO-1990011283-A1 | A PROCESS FOR THE PREPARATION OF 9-SUBSTITUTED GUANINE DERIVATIVES AND INTERMEDIATES FOR USE IN THE PROCESS | A/S GEA FARMACEUTISK FABRIK (DK) | 1990-10-04 | — | — | WO | disclosed |
| WO-1990006312-A1 | 2',3'-DIDEOXYRIBOFURANOSIDES AND PROCESS FOR PRODUCING THEM | INSTITUT FÜR MOLEKULARBIOLOGIE UND ANALYTIK (IMA) GMBH (DE) | 1990-06-14 | — | — | WO | disclosed |